Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 7.78M P/E - EPS this Y - Ern Qtrly Grth -
Income -4.23M Forward P/E - EPS next Y - 50D Avg Chg -37.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -74.00%
Dividend N/A Price/Book 0.67 EPS next 5Y - 52W High Chg -94.00%
Recommedations - Quick Ratio 0.36 Shares Outstanding 358.45M 52W Low Chg 37.00%
Insider Own 1.58% ROA -14.75% Shares Float 411.61M Beta -0.19
Inst Own 0.01% ROE -39.01% Shares Shorted/Prior -/- Price 0.02
Gross Margin - Profit Margin - Avg. Volume 574,206 Target Price -
Oper. Margin - Earnings Date - Volume 477,153 Change 0.00%
About REVIVE THERAPEUTICS LTD

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.

REVIVE THERAPEUTICS LTD News
11/12/24 Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
10/31/24 Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
06:00 AM Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
08/28/24 Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections
06/12/24 Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
06/10/24 Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
04/23/24 Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
06:00 AM Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
04/02/24 Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
03/27/24 Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillamine to Treat Long COVID
03/19/24 Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID
03/12/24 Revive Therapeutics Provides Corporate Update
02/26/24 Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
02/01/24 Revive Therapeutics Explores the Use of Bucillamine for Long COVID
01/31/24 Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500
01/24/24 Revive Therapeutics Ltd. Announces Offering of Up to $3 Million
01/16/24 Revive Therapeutics Provides Update Evaluating Bucillamine for Nerve Agent Exposure with Defence Research and Development Canada
01/10/24 Revive Therapeutics Successfully Completes Development of a Novel Lyophilized Formulation of Bucillamine
12/20/23 Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
07:00 AM Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine
RVVTF Chatroom

User Image Tartufo Posted - 3 days ago

$RVVTF decent volume again, LFG!

User Image MikeProZ Posted - 3 days ago

$RVVTF

User Image BaronXXII Posted - 4 days ago

$RVVTF .01... But 3M volume. Methinks somebody in CA knows something... Too bad we don't have any ACTUAL connections to MF.

User Image Tartufo Posted - 4 days ago

$RVVTF wow we hit a penny how exciting! Only .25 cents more to go and I will break even, lol

User Image Tartufo Posted - 4 days ago

$RVVTF the new administration may just be able to finally recognize Revive, volumes decent the past couple of days who knows. I still hold shares, GLTA!

User Image BaronXXII Posted - 5 days ago

$RVVTF $XXII And there's the TWEET from RFK! He's listening on Twitter!

User Image BaronXXII Posted - 5 days ago

$RVVTF RFK knows about psychedelics. Anything with psilocybin or ketamine should hit prime time. Watch for Big Pharma to try to take out little guys (micro caps) so they can quash the IP... $PFE $MRNA $PHRRF $GNLX

User Image Article_AI Posted - 5 days ago

$RVVTF Revive Therapeutics Explores Psilocybin for Stroke Treatment Revive Therapeutics (TSE:RVV) has released an update. Revive Therapeutics has announced promising research showcasing psilocybin’s potential as a t... https://www.stck.pro/news/RVVTF/93005874/

User Image Twits_Ghost Posted - 5 days ago

$DJT $RUM $RVVTF Yes let’s keep Billionaires and Corporations from paying any taxes ever!

User Image eon1111 Posted - 5 days ago

$RVVTF $DJT #TSLA $RUM

User Image MikeProZ Posted - 5 days ago

$RVVTF News Out - Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke

User Image Hiimbill Posted - 1 week ago

$RVVTF are these guys still playing the Covid card or have they gone back to sticking to the game plan? … just look south of us, the writing is on the wall with RFK supporting psychedelics

User Image BaronXXII Posted - 10/31/24

$RVVTF I notice a couple things that I believe are positive: - much more technical than previous "we're doing a study" PR. This likely means MF pulled from an interim research status report to build this PR. - moving to finding an appropriate dosage likely means that 'something' happened at a "regular" dose but they wonder if they quadruple the dose, will you get 4x performance? - previous PRs only mentioned Canadian DoD. Now I see FDA in the PR... This one's is a bit more of a tinfoil stretch; but still a consideration: has the Canadian study seen enough to call the FDA guys and say "hey, lol at this" - finally, adding in the TBI angle would really Garner attention if there's any merit. TBIs would represent a way bigger TAM than mustard gas...

User Image LOLROFLMAO Posted - 10/31/24

$RVVTF Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure Oct 31, 2024 https://revivethera.com/2024/10/revive-therapeutics-provides-update-on-research-study-evaluating-bucillamine-for-nerve-agent-exposure-2/

User Image BaronXXII Posted - 10/26/24

$RVVTF If MICHAEL HAD ANY SENSE LEFT... He would get buccilamine in front of RFK and generate BUZZ from Big Pharma SUPPRESSING buccilamine at the height of C0VID. That goddam Scott Gottlieb ... They got DIDDY pics of THAT MF.

User Image vic_li38 Posted - 10/20/24

$RVVTF Damn it’s been 4 years with this. Time flies when you’re getting fucked

User Image Bulldog_Retired Posted - 10/19/24

$RVVTF I know we're focused on Bucillamine vs Psilocybin, but another good article on PTSD applications https://www.washingtonpost.com/opinions/2024/09/16/shifts-psilocybin-facilitator-comic/

User Image Deutscher Posted - 4 weeks ago

$RVVTF FU RVVTF!

User Image LongBull67 Posted - 1 month ago

$RVVTF Just sold for a huge loss after years long hold. Can’t hang on any longer. Good luck to those buying/holding. You will need it!

User Image Mologan Posted - 09/19/24

$RVVTF can someone point me to a link re: Bucc and mustard gas, please? I’m reading the mustard gas isn’t really an issue or concern anymore.

User Image BaronXXII Posted - 1 month ago

$RVVTF I believe they got good news from the mustard gas review and have been told to "gear up" for an October announcement that this stuff works for lots of stuff... Hence the stopping off long covid test nonsense. 🤞

User Image Article_AI Posted - 1 month ago

$RVVTF Revive Therapeutics Prioritizes Bucillamine Development Revive Therapeutics (TSE:RVV) has released an update. Revive Therapeutics is shifting its resources to focus on the development of Bucillamine for ... https://www.stck.pro/news/RVVTF/89456845/

User Image OA_Trades Posted - 2 months ago

$RVVTF GL to all

User Image OA_Trades Posted - 2 months ago

$RVVTF Rounded tops. In my experience in TA , rounded tops start to form a pattern known as an Inverse Cup and Handle. Inverse Cup and Handles usually signal a continuation of the trend - in this case down. Will post and reshare this with the TA of an Inverse Cup and Handle.

User Image Hiimbill Posted - 2 months ago

$RVVTF where are all those fools that bought into this scam company when it mentioned getting into “coronavirus” vaccines 😂 Great buy guys 👏🏽 if you were too stupid to buy into this for that reason, then you deserve Pennie’s for the dollars you spent

User Image Tartufo Posted - 2 months ago

$RVVTF can't wrap my head around how I invested in this garbage company in the first place. Lesson learned; I hope lol

User Image BaronXXII Posted - 2 months ago

$RVVTF Up 25% today?

User Image BaronXXII Posted - 08/28/24

$RVVTF Monkey pox... Let's get the shit started already!

User Image Tartufo Posted - 08/28/24

$RVVTF What a joke of a company

User Image BaronXXII Posted - 08/28/24

$RVVTF Wow. He pivoted to mpox awfully fast... MF better be on the phone to people who can actually make introductions/seal deals because stupid MF lucky to even be grasping at straws at this point! Ego down. Phone up. Now.